NSE filing, NSE: PAR. Summary written from the filing by ALFA Finder's alert engine.
Par Drugs & Chemicals Ltd: key numbers
- Share price
- ₹114.96
- Market cap
- ₹141.4 Cr
- Revenue (annual)
- ₹103.7 Cr
- Net profit (annual)
- ₹13.11 Cr
- P/E (TTM)
- 9.8×Sector 46.1×
- Promoter holding
- 73.41%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Par Drugs & Chemicals Ltd
All →Par Drugs & Chemicals Board Meeting Date
Par Drugs and Chemicals Limited will hold a board meeting on October 29, 2026, to consider and approve its half-yearly unaudited financial results.
Par Drugs & Chemicals Other Announcement
The company submitted the routine Regulation 74(5) compliance certificate from its RTA regarding share dematerialization for the quarter ended September 30, 2026.
Par Drugs & Chemicals Management Change
Par Drugs re-appointed its statutory auditor and executive director/CEO. These appointments were approved at the company's 27th Annual General Meeting.
Par Drugs & Chemicals Annual General Meeting
Par Drugs and Chemicals Limited held its 27th Annual General Meeting on September 26, 2026. Management reviewed the company's financial performance and business affairs during the session.
Par Drugs & Chemicals Other Announcement
Par Drugs and Chemicals Limited is notifying shareholders about access to the FY 2025-26 Annual Report and 27th AGM notice via web-link.
Par Drugs & Chemicals Annual General Meeting
Par Drugs and Chemicals Limited has scheduled its 27th Annual General Meeting for September 26, 2026, in Vadodara to transact scheduled ordinary and special business.
Other management change announcements
All →iStreet Network Management Change
iStreet Network Ltd announced the resignation of Non-Executive Non-Independent Director Mr. Yash Maheshwari effective 13 October 2026. No financial impact is indicated.
Transgene Biotek Management Change
Transgene Biotek's statutory auditors Eswara Rao & Co. resigned effective 28 October 2026 citing pre-occupation. The company will appoint new auditors per applicable regulations.
Mobavenue AI Tech Management Change
Mobavenue AI Tech appointed Vikram Sheth as Chief of Corporate Development and Investor Relations. He will lead fundraising, acquisitions and investor relations.
Hexaware Technologies Management Change
Hexaware appointed Arjun Shah and Gregory Zeluck as Non-Executive Directors from 28 October 2026. Directors Neeraj Bharadwaj and Julius Genachowski resigned, and Girish Pai's resignation is effective 13 November 2026.
GMR Airports Management Change
GMR Airports appointed Sanjeev Gupta as Executive Director (Deputy CEO) effective 29 October 2026. Non-Executive Director Alexis Riols resigned effective 28 October 2026.
Raymond Realty Management Change
Raymond Realty said joint statutory auditor Chaturvedi & Shah LLP resigned on 28 October 2026 after a dispute over audit fee revision. Walker Chandiok & Co LLP continues as the other statutory auditor.